FDA to study celebrity, influencer drug endorsements
The study will look at how celebrity, physician, patient and influencer endorsements affect reactions to the product.
Regulatory
Government health officials stem panic over coronavirus
In states where coronavirus cases were confirmed, the state health departments took the lead.
Trump proposes changes to tobacco oversight
The Trump administration’s budget includes a proposal to remove tobacco product oversight from the FDA.
Digital health data laws look to enter the 21st century
Health data is governed by laws nearly 25 years old, and as more types of health data are created, from fitness to biometric to genetic data, Washington can’t keep up.
FDA clarifies biosimilar labeling, advertising guidelines
The FDA and FTC want to ensure companies don’t use anticompetitive practices to squash the biosimilar market.
FDA to study how drug names change patient, doctor perceptions
The agency is seeking public comment on the proposed study.
Democratic debate recap: Health insurance and drug prices get the spotlight
The last Democratic debate before the Iowa caucuses focused more on foreign policy than healthcare.
Appeals court considers HHS’ TV drug price disclosure rule
The appeals court questioned HHS’ authority and whether the list price would only confuse consumers.
Dive into the FDA ban on flavored e-cigarettes
Beginning Feb. 1, the e-cigarette industry will look much different.
Questions linger after Hahn takes over as FDA commissioner
Some Senators who questioned Hahn during his confirmation hearing expressed concern about his lack of regulatory and public policy experience.
Want to read more?
Please login or register first to view this content.
